Piper Sandler believes that the overall uptrend in markets remains intact, adding that traders and investors should look to buy the dip on pullbacks. Read more here.

Piper Sandler upgraded Campbell (CPB) to Overweight from Neutral with a price target of $56, up from $47. The firm is citing better long-term ...

Dogecoin shot higher on Tuesday night after President-elect Donald Trump formally announced the creation of the Department of ...

Ahead of Nvidia's earnings report, Piper Sandler raised its price target on Nvidia from $140 to $175, maintaining its overweight rating on the stock and calling the stock its top large-cap pick, ...

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of ...

We recently compiled a list of the 14 AI News You Should Pay Attention To. In this article, we are going to take a look at ...

Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential ...

While tiny, the week’s increase in total application volume marked the first rise in overall demand in seven weeks.

Ahead of Nvidia's earnings report, Piper Sandler raised its price target on Nvidia from $140 to $175, maintaining its ...

Banks are under pressure to kick criminals off their platforms and compensate more victims as regulators and lawmakers focus ...

OrthoPediatrics Corp. ("OrthoPediatrics” or the "Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & ...

Fintel reports that on November 11, 2024, Piper Sandler downgraded their outlook for Xeris Biopharma Holdings (NasdaqGS:XERS) ...